Baicalin From Scutellaria baicalensis Impairs Th1 Polarization Through Inhibition of Dendritic Cell Maturation
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q3Scopus Q2
- 저널
- JOURNAL OF PHARMACOLOGICAL SCIENCES121(2) · pp.148 · 2013
- 피인용
- Web of Science 30
- JCR IF
- JCR 2012 2.15
- ISSN
- 1347-8613
저자
- Kim, Mi Eun제1저자Department of Biology, College of Natural Sciences, Chosun University, South Korea
- Kim, Hyung KeunHeart Research Center of Chonnam National University Hospital, Cardiovascular Research Institute, Chonnam National University, South Korea
- Park, Hyeon-YoungDepartment of Biology, College of Natural Sciences, Chosun University, South Korea
- 김대현Molecular Inflammation Research Center for Aging Intervention (MRCA), Department of Pharmacy, Pusan National University, South Korea
- 정해영Molecular Inflammation Research Center for Aging Intervention (MRCA), Department of Pharmacy, Pusan National University, South Korea
- Lee, Jun Sik교신저자Department of Biology, College of Natural Sciences, Chosun University, South Korea
초록
Baicalin from Scutellaria baicalensis is a major flavonoid constituent found in the traditional Chinese medicinal herb Baikal skull cap. It has been widely used for the treatment of various diseases such as pneumonia, diarrhea, and hepatitis. Recent studies have demonstrated that baicalin possesses a wide range of pharmacological and biological activities, including anti-inflammatory, anti-microbial, anti-oxidant, and anti-tumor properties. Specifically, its anti-inflammatory activity has been estimated in various animal models of acute and chronic inflammation; however, its effects on dendritic cells (DCs) maturation and immuno-stimulatory activities are still unknown. In this study, we attempted to determine whether baicalin could influence DC surface molecule expression, antigen uptake capacity, cytokine production, and capacity to induce T-cell differentiation. Baicalin was shown to significantly suppress the expression of surface molecules CD80, CD86, major histocompatibility complex (MHC) class I, and MHC class II as well as the levels of interleukin-12 production in lipopolysaccharide stimulated DCs. Moreover, baicalin-treated DCs showed an impaired induction of the T helper type 1 immune response and a normal cell-mediated immune response. These findings provide important understanding of the immunopharmacological functions of baicalin and have ramifications for the development of therapeutic adjuvants for the treatment of DCs-related acute and chronic diseases.
키워드
baicalindendritic cellcytokineTh1 polarizationIN-VITROCANCER-CELLST-CELLSTRANSPLANTATIONIMMUNOTHERAPYCOMBINATIONAPOPTOSISVIVO
식별자
- WoS UID
- 000318453100008



로그인
연구물 목록으로